Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Neurocrine Bioscienc
(NQ:
NBIX
)
152.81
+0.24 (+0.16%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Neurocrine Bioscienc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Why the quality investor may take a look at NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX).
August 22, 2024
Is NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) suited for quality investing?
Via
Chartmill
Evaluating Neurocrine Biosciences: Insights From 15 Financial Analysts
August 19, 2024
Via
Benzinga
NASDAQ:NBIX—A High-Growth Stock Gearing Up for Its Next Upward Move.
August 19, 2024
NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX): a strong growth stock preparing for the next leg up?.
Via
Chartmill
NASDAQ:NBIX is not too expensive for the growth it is showing.
August 19, 2024
Don't overlook NASDAQ:NBIX—a stock with solid growth prospects and a reasonable valuation.
Via
Chartmill
9 Health Care Stocks Whale Activity In Today's Session
August 13, 2024
Via
Benzinga
So Much For Expecting The Fed To Stick The Landing
August 04, 2024
Now is not the time to be fully invested.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
A Closer Look at 7 Analyst Recommendations For Neurocrine Biosciences
August 01, 2024
Via
Benzinga
NASDAQ:NBIX, a strong growth stock, setting up for a breakout.
July 26, 2024
NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX): a strong growth stock preparing for the next leg up?.
Via
Chartmill
NASDAQ:NBIX, a growth stock which is not overvalued.
July 26, 2024
Looking for growth without the hefty price tag? Consider NASDAQ:NBIX.
Via
Chartmill
Stock Market Takes Bearish Turn; Apple, Microsoft, Meta, Amazon, AMD In Focus: Weekly Review
August 02, 2024
Apple and Meta had strong results, while AI spending remains robust.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Should Quality Investors Include NASDAQ:NBIX in Their Portfolio?
July 25, 2024
Why Quality Investors May Find NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Attractive.
Via
Chartmill
Cracking The Code: Understanding Analyst Reviews For Neurocrine Biosciences
July 10, 2024
Via
Benzinga
Why NASDAQ:NBIX Is a Promising High-Growth Stock in the Midst of Consolidation.
July 05, 2024
NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX), a strong growth stock, setting up for a breakout.
Via
Chartmill
Key Takeaways From Neurocrine Biosciences Analyst Ratings
May 28, 2024
Via
Benzinga
Exploring NASDAQ:NBIX's quality characteristics.
May 27, 2024
Reasonable growth and debt and a high ROIC for NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX).
Via
Chartmill
Exploring the Growth Potential of NASDAQ:NBIX as It Nears a Breakout.
May 24, 2024
NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) qualifies as a high growth stock and is consolidating.
Via
Chartmill
NASDAQ:NBIX is not too expensive for the growth it is showing.
July 05, 2024
Don't overlook NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX)—a stock with solid growth prospects and a reasonable valuation.
Via
Chartmill
Reasonable Growth, Debt Levels, and a High ROIC Make NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Appealing to Quality Investors.
July 04, 2024
Why NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) qualifies as a quality stock.
Via
Chartmill
Despite its impressive fundamentals, NASDAQ:NBIX remains undervalued.
June 20, 2024
NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX), an undervalued stock with good fundamentals.
Via
Chartmill
7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
June 17, 2024
With biotech stocks enjoying a permanently relevant narrative, investors should focus on these compelling opportunities.
Via
InvestorPlace
Is NASDAQ:NBIX on the Verge of a Major Breakout as a Strong Growth Stock?
June 14, 2024
Is NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) on the Verge of a Major Breakout as a Strong Growth Stock?
Via
Chartmill
Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans
June 14, 2024
Neurocrine Biosciences has long been known for its blockbuster drug Ingrezza. It's diversifying, developing multiple drugs in related areas.
Via
Investor's Business Daily
In the world of growth stocks, NASDAQ:NBIX shines as a value proposition.
May 23, 2024
Looking for growth without the hefty price tag? Consider NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX).
Via
Chartmill
Why Quality Investors May Find NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Attractive.
May 03, 2024
Why the quality investor may take a look at NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX).
Via
Chartmill
NASDAQ:NBIX, a strong growth stock, setting up for a breakout.
May 02, 2024
Is NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) on the Verge of a Major Breakout as a Strong Growth Stock?
Via
Chartmill
Don't overlook NASDAQ:NBIX—a stock with solid growth prospects and a reasonable valuation.
June 13, 2024
Investors should take note ofNEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX), a growth stock that remains attractively priced.
Via
Chartmill
Nvidia Leads Five Stocks Near Buy Points As Market Rally Picks Up Steam
May 04, 2024
The market rally appears to be picking up steam.
Via
Investor's Business Daily
A Week Of Fast-Moving Stocks Ahead: Disney, Toyota, Ferrari, Constellation
May 03, 2024
Earnings season moves into final innings, some fast-moving names led by Disney, Ferrari and Constellation report.
Via
Investor's Business Daily
Stock Market Rallies On Fed, Jobs Report, Apple: Weekly Review
May 03, 2024
The Nasdaq regained its 50-day line Friday. The other indexes hit resistance.
Via
Investor's Business Daily
Topics
Economy
Exposures
Interest Rates
Despite its growth, NASDAQ:NBIX remains within the realm of affordability.
May 02, 2024
Investors should take note of NASDAQ:NBIX, a growth stock that remains attractively priced.
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.